UKHSA’s flagship SIREN study enters new phase to continue surveillance of respiratory pathogens

The next phase of the study will be known as SIREN 2.0 and began in September 2023.

New discovery reveals how muscles sense mechanical pressure

A new study from Umeå University, Sweden, shows that the body’s muscles sense mechanical pressure.

September 10, 2024

Ventyx axes development of TYK2 inhibitor following Phase 2 failure

Ventyx Biosciences is shelving a drug after a mid-stage miss and failure. The company was investigating VTX958, an allosteric TYK2 inhibitor, in patients with moderately

July 30, 2024

Lykos Therapeutics Makes Progress in Europe

The TDR Three Key Takeaways regarding Lykos Therapeutics and PTSD Therapy: Lykos Therapeutics achieves a major milestone with Phase 2 trials in Europe. MDMA-assisted therapy

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.